5T4 oncofetal antigen expression in ovarian carcinoma
- 1 June 1995
- journal article
- research article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 5 (4) , 269-274
- https://doi.org/10.1046/j.1525-1438.1995.05040269.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Minimal residual disease as the target for immunotherapy of cancerThe Lancet, 1994
- Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinomaThe Lancet, 1994
- Prognostic significance of 5T4 oncofetal antigen expression in colorectal carcinomaBritish Journal of Cancer, 1994
- Isolation of a cDNA encoding 5T4 oncofetal trophoblast glycoprotein. An antigen associated with metastasis contains leucine-rich repeats.Journal of Biological Chemistry, 1994
- The expression of 5T4 antigen in colorectal and gastric carcinomaBritish Journal of Cancer, 1992
- Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancerThe Lancet, 1992
- Isolation and characterization of 5T4, a tumour‐associated antigenInternational Journal of Cancer, 1990
- Immunohistological distribution of 5T4 antigen in normal and malignant tissuesBritish Journal of Cancer, 1990
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976